Development and progress of fluorescence imaging technology in diagnosis and treatment of oral cancer

doi:10.19401/j.cnki.1007-3639.2023.09.008

Abstract

Abstract:

The main clinical problems in treatment of oral cancer are tumor recurrence and metastasis after surgery. To improve the efficiency of resection and the prognosis of patients is a key to curing oral cancer. Fluorescence imaging, as an adjuvant in the diagnosis and treatment of oral cancer with no invasion and radiation, can provide real-time and ultrahigh-resolution graphics for preoperative tumor diagnosis, intraoperative tumor margin determination and postoperative tumor bed checking, which can help reduce the recurrent rate, enhance the survival rate and improve the life quality of patients. This article reviewed several typical fluorescent probes and discussed their characteristics, limitations and application prospects in clinic or research for oral cancer.

Key words: Oral cancer, Fluorescence imaging technology, Fluorescent probe, Diagnosis

CLC Number:

R739.85

XU Hongtao, HUANG Xiaojuan, ZHENG Chongyang, ZHANG Zhiyuan. Development and progress of fluorescence imaging technology in diagnosis and treatment of oral cancer[J]. China Oncology, 2023, 33(9): 874-878.

References 22

[1]	ZHENG C Y, ZHANG X Y, WANG L T, et al. Versatile cobalt-glycerate nanoplatform for MR-guided neoadjuvant photo-therapy of oral squamous cell carcinoma[J]. Chem Eng J, 2022, 437: 135476. doi: 10.1016/j.cej.2022.135476
[2]	KAIN J J, BIRKELAND A C, UDAYAKUMAR N, et al. Surgical margins in oral cavity squamous cell carcinoma: current practices and future directions[J]. Laryngoscope, 2020, 130(1): 128-138. doi: 10.1002/lary.v130.1
[3]	CHIOSEA S I. Intraoperative margin assessment in early oral squamous cell carcinoma[J]. Surg Pathol Clin, 2017, 10(1): 1-14. doi: S1875-9181(16)30089-7 pmid: 28153128
[4]	CWALINSKI T, POLOM W, MARANO L, et al. Methylene blue-current knowledge, fluorescent properties, and its future use[J]. J Clin Med, 2020, 9(11): 3538. doi: 10.3390/jcm9113538
[5]	WAQAS M, SHAMIM M S. Sodium fluorescein guided resection of malignant glioma[J]. J Pak Med Assoc, 2018, 68(6): 968-970. pmid: 30323373
[6]	HARA T, INAMI M, HARA T. Efficacy and safety of fluorescein angiography with orally administered sodium fluorescein[J]. Am J Ophthalmol, 1998, 126(4): 560-564. doi: 10.1016/s0002-9394(98)00112-3 pmid: 9780101
[7]	QAISER D, SOOD A, MISHRA D, et al. Novel use of fluorescein dye in detection of oral dysplasia and oral cancer[J]. Photodiagnosis Photodyn Ther, 2020, 31: 101824. doi: 10.1016/j.pdpdt.2020.101824
[8]	DU L Z, MA S W, WEN X, et al. Oral squamous cell carcinoma cells are resistant to doxorubicin through upregulation of miR-221[J]. Mol Med Rep, 2017, 16(3): 2659-2667. doi: 10.3892/mmr.2017.6915
[9]	LE M N, WUERTZ B R, BIEL M A, et al. Effects of methylene blue photodynamic therapy on oral carcinoma and leukoplakia cells[J]. Laryngoscope Investig Otolaryngol, 2022, 7(4): 982-987. doi: 10.1002/lio2.772 pmid: 36000031
[10]	VISHNOI J R, KUMAR V, GUPTA S, et al. Outcome of sentinel lymph node biopsy in early-stage squamous cell carcinoma of the oral cavity with methylene blue dye alone: a prospective validation study[J]. Br J Oral Maxillofac Surg, 2019, 57(8): 755-759. doi: S0266-4356(19)30247-5 pmid: 31303357
[11]	ZHENG W, OLIVO M, SOO K C. The use of digitized endoscopic imaging of 5-ALA-induced PPⅨ fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo[J]. Int J Cancer, 2004, 110(2): 295-300. doi: 10.1002/(ISSN)1097-0215
[12]	REINHART M B, HUNTINGTON C R, BLAIR L J, et al. Indocyanine green: historical context, current applications, and future considerations[J]. Surg Innov, 2016, 23(2): 166-175. doi: 10.1177/1553350615604053 pmid: 26359355
[13]	SHINDY H A. Fundamentals in the chemistry of cyanine dyes: a review[J]. Dyes Pigments, 2017, 145: 505-513. doi: 10.1016/j.dyepig.2017.06.029
[14]	PAN J R, DENG H, HU S Q, et al. Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC[J]. World J Surg Oncol, 2020, 18(1): 96. doi: 10.1186/s12957-020-01874-z pmid: 32414418
[15]	LEE Y J, KRISHNAN G, NISHIO N, et al. Intraoperative fluorescence-guided surgery in head and neck squamous cell carcinoma[J]. Laryngoscope, 2021, 131(3): 529-534. doi: 10.1002/lary.v131.3
[16]	VAN SCHAIK J E, HALMOS G B, WITJES M J H, et al. An overview of the current clinical status of optical imaging in head and neck cancer with a focus on Narrow Band imaging and fluorescence optical imaging[J]. Oral Oncol, 2021, 121: 105504. doi: 10.1016/j.oraloncology.2021.105504
[17]	BHANDARI C, FAKHRY J, EROY M, et al. Towards photodynamic image-guided surgery of head and neck tumors: photodynamic priming improves delivery and diagnostic accuracy of cetuximab-IRDye800CW[J]. Front Oncol, 2022, 12: 853660. doi: 10.3389/fonc.2022.853660
[18]	ROSENTHAL E L, WARRAM J M, DE BOER E, et al. Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer[J]. Clin Cancer Res, 2015, 21(16): 3658-3666. doi: 10.1158/1078-0432.CCR-14-3284 pmid: 25904751
[19]	ZHU S J, TIAN R, ANTARIS A L, et al. Near-infrared-Ⅱ molecular dyes for cancer imaging and surgery[J]. Adv Mater, 2019, 31(24): e1900321.
[20]	ZHOU J, LIU Z, LI F Y. Upconversion nanophosphors for small-animal imaging[J]. Chem Soc Rev, 2012, 41(3): 1323-1349. doi: 10.1039/c1cs15187h pmid: 22008740
[21]	LIN B, WU J, WANG Y X, et al. Peptide functionalized upconversion/NIR-Ⅱ luminescent nanoparticles for targeted imaging and therapy of oral squamous cell carcinoma[J]. Biomater Sci, 2021, 9(3): 1000-1007. doi: 10.1039/D0BM01737J
[22]	ZHU C N, CHEN G, TIAN Z Q, et al. Near-infrared fluorescent Ag2Se-cetuximab nanoprobes for targeted imaging and therapy of cancer[J]. Small, 2017, 13(3).